Chapter 227 All intracranial tumors carry a poor prognosis; however, often it is difficult to discuss prognosis because treatment sometimes is initiated without a definitive diagnosis. Definitive treatment relies on an accurate histopathologic tumor diagnosis, although correlations between tumor appearance on magnetic resonance imaging (MRI) and histopathologic diagnoses have been reported (Kraft et al, 1997; Snyder et al, 2006). The patient’s prognosis is related to tumor biologic behavior, as well as severity and progression of clinical signs. Without treatment intracranial tumors offer a grave prognosis. In addition, these patients often have elevated intracranial pressure; thus the anesthetist should take measures to avoid or reduce intracranial hypertension, including maintaining normotension (systolic blood pressure of 110 to 160 mm Hg or mean arterial pressure of 80 to 110 mm Hg), eucarbia (35 to 45 mm Hg), and analgesia. Inhalant anesthetics increase cerebral blood flow (see Chapter 13), which can lead to or potentiate intracranial hypertension; injectable agents such as propofol and fentanyl can be used to decrease the requirement of inhalant anesthetics. Diuretics and glucocorticoids may be given to decrease brain edema (Table 227-1). Intracranial surgery can be associated with intraoperative hemorrhage; thus one should be prepared for a blood transfusion. After surgery the patient should be allowed to recover gradually from anesthesia. It is critically important to avoid excitement on recovery, and additional sedation may be required. Analgesia should be continued and titrated to the patient’s needs. TABLE 227-1 Medications Used in the Treatment of Intracranial Tumors Surgical removal of feline meningiomas may be curative since the entire mass often can be removed in total. Accordingly, surgical excision is the treatment of choice for feline meningiomas. Troxel and associates (2003) reported that cats treated by surgical removal of meningiomas had a significantly longer survival time than cats treated by any other modality (Table 227-2). Niebauer and colleagues (1991) reported that 50% of cats were alive 2 years after surgery. TABLE 227-2 Comparison of Median Survival Times in Dogs and Cats with Intracranial Tumors Treated with Surgical Excision and/or Irradiation
Treatment of Intracranial Tumors
Definitive Therapies
Surgical Excision
Anesthetic Considerations
Drug
Dosage
Use/Indication
Carmustine
50 mg/ml q6wk IV (over 15-20 min)
Nitrosourea chemotherapeutic agent; may be used to treat meningioma and glioma
Cefazolin
22 mg/kg q90min IV
Perioperative antibiotic
Cytarabine (cytosine arabinoside)
20-100 mg/m2 q1wk intrathecally; 50 mg/m2 SC for 2 days. Repeat every 3 weeks
Chemotherapeutic agent used to treat CNS lymphoma
Diazepam and midazolam
0.5 mg/kg as needed IV; or 2 mg/kg as needed per rectum
Anticonvulsant used in emergency management of status epilepticus or cluster seizures
Dimenhydrinate
Dog: 25-50 mg q8-24h PO
Cat: 12.5 mg q8-24h PO
Antihistamine used as antiemetic in vestibular disease
Hydroxyurea
Dog: 50 mg/kg once daily, 3 days per week POCat: 25 mg/kg once daily, 3 days per week PO
Chemotherapeutic agent; may be used to treat meningioma
Levetiracetam
20 mg/kg q8h PO
20-60 mg/kg IV for status epilepticus
Anticonvulsant
Lomustine
Dog: 60-90 mg/m2 q3-6wk PO
Cat: 50-60 mg/m2 q6wk PO
Nitrosourea chemotherapeutic agent; may be used to treat meningioma and glioma
Mannitol
0.5-1 g/kg q4h or as needed IV
Osmotic diuretic used to decrease brain edema and lower intracranial pressure
Meclizine
25 mg/dog and 12.5 mg/cat q24h PO
Antihistamine used as antiemetic in vestibular disease
Methylprednisolone sodium succinate
30 mg/kg once IV; or 100 mg/kg given over 24 hr IV
Glucocorticoid used to decrease peritumoral brain edema and lower intracranial pressure
7.5% NaCl
5-20 ml/kg as needed IV
Osmotic diuretic used to decrease brain edema and lower intracranial pressure
Phenobarbital
Loading dosage: 5 mg/kg as needed IV (up to 20 mg/kg total)
Maintenance dosage: 2-8 mg/kg q12h PO (Adjust dose by monitoring blood concentrations)
Anticonvulsant
Potassium bromide
Loading dosage: 200 mg/kg per day every 3-5 days
Maintenance dosage: 30-40 mg/kg q24h PO
Anticonvulsant
Prednisone
0.5-1 mg/kg q12h PO
Glucocorticoid used for supportive treatment of intracranial tumors
Zonisamide
10 mg/kg q12h PO
Anticonvulsant
Meningioma
You may also need
Treatment of Intracranial Tumors
Only gold members can continue reading. Log In or Register a > to continue
WordPress theme by UFO themes